Setting up a lung cancer screening program

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 10, Issue 2, 2012, Pages 277-285

  Arenberg, Douglas ^a   Kazerooni, Ella A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CT scan; Lung cancer; Prevention; Risk assessment; Screening; Tobacco

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DATA COLLECTION METHOD; FOLLOW UP; HUMAN; LUNG CANCER; PRACTICE GUIDELINE; PREDICTIVE VALUE; REVIEW; SCREENING TEST; SMOKING; SMOKING CESSATION;

EID: 84856871689     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2012.0024     Document Type: Review

References (39)

1. Lung cancer trial results show mortality benefit with low-dose CT [press release]. Bethesda, Maryland: National Institutes of Health; November 4, 2010. Available at: http://www.nih.gov/news/health/nov2010/nci-04.htm. Accessed January 9, 2012.
2. Wood DE, Eapen GA, Ettinger DS, et al. NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 1, 2012. Available at: http://www.nccn.org/professionals/physician-gls/pdf/lung-screening.pdf. Accessed January 9, 2012.
3. Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253.
4. Hillman BJ. Economic, legal, and ethical rationales for the ACRIN national lung screening trial of CT screening for lung cancer. Acad Radiol 2003;10:349-350. (Pubitemid 36259209)
5. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400.WW (Pubitemid 41507873)
6. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
7. Aberle DR, Adams AM, Berg CD, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102:1771-1779.
8. Fukuda M, Nakamura Y, Kasai T, et al. A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer. J Thorac Oncol 2009;4:741-745.
9. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-276. (Pubitemid 351161249)
10. D'Amelio AM Jr, Cassidy A, Asomaning K, et al. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer 2010;103:423-429.
11. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-478. (Pubitemid 36432421)
12. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-726. (Pubitemid 47073532)
13. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103:1058-1068.
14. Paz-Elizur T, Krupsky M, Blumenstein S, et al. DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst 2003;95:1312-1319. (Pubitemid 37160864)
15. Blomquist T, Crawford EL, Mullins D, et al. Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis. Cancer Res 2009;69:8629-8635.
16. Willey JC, Knight CR, Crawford EL, et al. Use of standardized reverse transcription-polymerase chain reaction and the standardized expression measurement center in multi-institutional trials to develop meaningful lung cancer classification based on molecular genetic criteria. Chest 2004;125(Suppl 5):155S-156S. (Pubitemid 38648371)
17. Gao WM, Kuick R, Orchekowski RP, et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 2005;5:110.
18. Field JK, Brambilla C, Caporaso N, et al. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol 2002;21:369-373.
19. Gorlova OY, Amos C, Henschke C, et al. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Hum Hered 2003;56:139-145. (Pubitemid 37465080)
20. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 2008;1:250-254.
21. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-265. (Pubitemid 40432263)
22. Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771. (Pubitemid 44631359)
23. Jacobs PC, Mali WP, Grobbee DE, et al. Prevalence of incidental findings in computed tomographic screening of the chest: a systematic review. J Comput Assist Tomogr 2008;32:214-221. (Pubitemid 351489441)
24. Rampinelli C, Preda L, Maniglio M, et al. Extrapulmonary malignancies detected at lung cancer screening. Radiology 2011;261:293-299.
25. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005;294:1505-1510. (Pubitemid 41362687)
26. Ebbert J, Yang P, Vachon C, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003;21:921-926. (Pubitemid 46606453)
27. Prochaska JO, DiClemente CC, Velicer WF, et al. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 1993;12:399-405.
28. Lafata JE, Simpkins J, Lamerato L, et al. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev 2004;13:2126-2132. (Pubitemid 40054307)
29. Doi S, Soda H, Oka M, et al. The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Mol Cancer Ther 2004;3:1397-1402. (Pubitemid 39562584)
30. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-2229.
31. Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(Suppl 3):108S-130S. (Pubitemid 47502803)
32. Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-855. (Pubitemid 28337035)
33. Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007;132(Suppl 3):161S-77S. (Pubitemid 47502806)
34. Mirtcheva RM, Vazquez M, Yankelevitz DF, et al. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Clin Imaging 2002;26:95-100. (Pubitemid 34163278)
35. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.
36. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001;345:181-188. (Pubitemid 32662128)
37. Alberts WM. Introduction: diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest 2007;132(Suppl 3):20S-22S. (Pubitemid 47502796)
38. Eisenberg RL, Bankier AA, Boiselle PM. Compliance with Fleischner Society guidelines for management of small lung nodules: a survey of 834 radiologists. Radiology 2010;255:218-224.
39. Sox HC. Better evidence about screening for lung cancer. N Engl J Med 2011;365:455-457.